Clinical experience with non-nucleoside reverse transcriptase inhibitors.
Miller
V
V
Department of Infectious Diseases, J.W.-Goethe University, Frankfurt, Germany.
Staszewski
S
S
Boucher
C A
CA
Phair
J P
JP
D000081:Acetamides / Q000494:pharmacology*; D000098:Acetophenones / Q000494:pharmacology*; D000818:Animals; D019380:Anti-HIV Agents / Q000494:pharmacology*; D020008:Delavirdine / Q000494:pharmacology*; D006678:HIV / Q000187:drug effects*; D015658:HIV Infections / Q000188:drug therapy*; D019829:Nevirapine / Q000494:pharmacology*; D009705:Nucleosides; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology*
D000081:Acetamides; D000098:Acetophenones; D019380:Anti-HIV Agents; D009705:Nucleosides; D018894:Reverse Transcriptase Inhibitors; C080073:loviride; D019829:Nevirapine; D020008:Delavirdine